Argenx
ARGX
#571
Rank
A$55.70 B
Marketcap
$931.66
Share price
1.54%
Change (1 day)
23.52%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$6.30

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$6.40. In 2022 the company made an earnings per share (EPS) of -$20.17.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.30-68.77%
2022-$20.17